{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:39Z","timestamp":1767135039465,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":65,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005399.pub2","type":"reference-entry","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T10:37:15Z","timestamp":1183459035000},"source":"Crossref","is-referenced-by-count":9,"title":["Pharmacological interventions for epilepsy in people with intellectual disabilities"],"prefix":"10.1002","author":[{"given":"Janine","family":"Beavis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Dojcinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0387-7604(12)80052-0","article-title":"Double-blind placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy","volume":"13","author":"Battaglia","year":"1991","journal-title":"Brain & Development"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1059-1311(00)90474-6","article-title":"A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy","volume":"10","author":"Crawford","year":"2001","journal-title":"Seizure"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1528-1157.1989.tb05321.x","article-title":"Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut Syndrome","volume":"30","author":"Crumrine","year":"1989","journal-title":"Epilepsia"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","article-title":"The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study","volume":"39","author":"Eriksson","year":"1998","journal-title":"Epilepsia"},{"issue":"63","key":"10.1002\/14651858.CD005399.pub2-BIB5|cit5","first-page":"417","article-title":"Ineffectiveness of add-on treatment with flunarizine in patients with epilepsy and mental retardation","volume":"62","author":"Gigli","year":"1988","journal-title":"Il Bolletino della Lega Italiana contro l'Epilessia"},{"issue":"21","key":"10.1002\/14651858.CD005399.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB7|cit7","first-page":"231","article-title":"Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation","volume":"35","author":"Kaski","year":"1991","journal-title":"Journal of Mental Deficiency Research"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.yebeh.2005.07.006","article-title":"A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life","volume":"7","author":"Kerr","year":"2005","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD005399.pub2-BIB9|cit9","first-page":"92","article-title":"Double-blind, placebo-controlled evaluation of the safety and efficacy of lamotrigine (Lamictal) for the treatment of patients with a clinical diagnosis of Lennox-Gastaut syndrome","volume":"37 (Suppl 4)","author":"Billard","year":"1996","journal-title":"Epilepsia"},{"issue":"25","key":"10.1002\/14651858.CD005399.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005399.pub2-BIB11|cit11","first-page":"163","article-title":"Improved neurological function accompanies effective control of the Lennox-Gastaut syndrome with Lamictal: results of a multinational, placebo-controlled trial","volume":"37 (Suppl 5)","author":"Mullens","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1111\/j.1528-1157.1994.tb05969.x","article-title":"Felbamate in the treatment of Lennox-Gastaut syndrome","volume":"35 (Suppl 5)","author":"Jensen","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB13|cit13","first-page":"13","article-title":"A double-blind trial of felbamate in Lennox-Gastaut syndrome","volume":"32 (Suppl 3)","author":"Ritter","year":"1991","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox- Gastaut syndrome)","volume":"328","author":"Ritter","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005399.pub2-BIB15|cit15","first-page":"63","article-title":"Clinical experience with Felbamate in paediatric age","volume":"86-87","author":"Vigevano","year":"1994","journal-title":"Lega Italiana conto l'Epilessia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB16|cit16","first-page":"131","article-title":"A double-blind trial of topiramate in Lennox-Gastaut syndrome (LGS)","volume":"38 (Suppl 3)","author":"Glauser","year":"1997","journal-title":"Epilepsia"},{"issue":"9","key":"10.1002\/14651858.CD005399.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005399.pub2-BIB18|cit18","first-page":"155","article-title":"The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome (LGS)","volume":"37 (Suppl 5)","author":"Oletsky","year":"1996","journal-title":"Epilepsia"},{"issue":"2-3","key":"10.1002\/14651858.CD005399.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0920-1211(98)00119-3","article-title":"The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome","volume":"34","author":"Siegel","year":"1999","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3805\/jjes.15.110","article-title":"Single blind comparative study of clobazam (NH-15) with clonazepam in intractable childhood epilepsies","volume":"15","author":"Yamatogi","year":"1997","journal-title":"Journal of the Japan Epilepsy Society"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub2-BIB21|cit21","first-page":"268","article-title":"Clonazepam: its efficacy in association with phenytoin and phenobarbital in mental patients with generalized major motor seizures","volume":"16","author":"Bielmann","year":"1978","journal-title":"International Journal of Clinical Pharmacology and Biopharmacy"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/01.wnl.0000230138.46508.5b","article-title":"Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures","volume":"67","author":"Donati","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005399.pub2-BIB23|cit23","first-page":"118","article-title":"Long-term follow-up of felbamate treatment in children with Lennox-Gastaut Syndrome","volume":"33","author":"Espe-Lillo","year":"1992","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1528-1157.1989.tb05322.x","article-title":"Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study","volume":"30","author":"Luna","year":"1989","journal-title":"Epilepsia"},{"issue":"10","key":"10.1002\/14651858.CD005399.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1469-8749.1994.tb11777.x","article-title":"A simple, effective and well-tolerated treatment regime for West syndrome","volume":"36","author":"Schlumberger","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"231","key":"10.1002\/14651858.CD005399.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/adc.43.231.616","article-title":"Psychometric study of children with learning problems and 14-6 positive spike EEG patterns, treated with ethosuximide (Zarontin) and placebo","volume":"43","author":"Smith","year":"1968","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub2-BIB27|cit27","first-page":"158","article-title":"Clinico-electroencephalographic evaluation of a new benzodiazepine (Ro 05-4023) by oral administration in epileptic patients by double blind technique","volume":"16","author":"Turner","year":"1970","journal-title":"Acta Neurologica Latinoamericana"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/JCP.0b013e3181b639b4","article-title":"Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities?","volume":"29","author":"Hellings","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD005399.pub2-BIB29|cit29","unstructured":"Bjulruf B Comparing ketogenic diet with the most appropriate antiepileptic drug - a randomized study of children with mental retardation and drug resistant epilepsy www.clinicaltrials.gov\/ct\/show\/NCT00552526"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1157.1998.tb01373.x","article-title":"Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"issue":"7","key":"10.1002\/14651858.CD005399.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002018-200124070-00004","article-title":"Behavioural effects of the new anticonvulsants","volume":"24","author":"Besag","year":"2001","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2788.1992.tb00533.x","article-title":"Behaviour and psychiatric disorders of people with mental handicaps living in the community","volume":"36","author":"Bouras","year":"1992","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2788.2000.00270.x","article-title":"Epilepsy and intellectual disability","volume":"44","author":"Bowley","year":"2000","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1002\/14651858.CD005399.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1016\/0140-6736(90)90388-L","article-title":"Vigabatrin and behaviour disturbances (Letter)","volume":"335","author":"Dam","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005399.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1192\/bjp.159.6.822","article-title":"Psychopathology of people with mental handicap and epilepsy. I: Maladaptive behaviour","volume":"159","author":"Deb","year":"1991","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0010-440X(97)90072-9","article-title":"Mental disorder in adults with mental retardation and epilepsy","volume":"38","author":"Deb","year":"1997","journal-title":"Comprehensive Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/1999\/538368","article-title":"Psychiatric illness and behavioural problems in adults with learning disability and epilepsy","volume":"11","author":"Deb","year":"1998","journal-title":"Behavioural Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0790966700004948","article-title":"Characteristics of epilepsy in a population based cohort of adults with learning disability","volume":"16","author":"Deb","year":"1999","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005399.pub2-BIB39|cit39","first-page":"S30","article-title":"Vigabatrin in childhood epilepsy","volume":"6","author":"Dulac","year":"1991","journal-title":"Journal of Child Neurology"},{"issue":"10","key":"10.1002\/14651858.CD005399.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.139.10.1297","article-title":"Psychiatric disorders in the mentally retarded: types, problems, and challenges","volume":"139","author":"Eaton","year":"1982","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005399.pub2-BIB41|cit41","first-page":"123","article-title":"The mentally handicapped person with epilepsy: a comparative study investigating psychosocial functioning","volume":"33","author":"Espie","year":"1989","journal-title":"Journal of Mental Deficiency Research"},{"issue":"4","key":"10.1002\/14651858.CD005399.pub2-BIB42|cit42","first-page":"351","article-title":"Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community","volume":"34","author":"Espie","year":"1990","journal-title":"Journal of Mental Deficiency Research"},{"issue":"8","key":"10.1002\/14651858.CD005399.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1528-1157.1998.tb01183.x","article-title":"Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation","volume":"39","author":"Ettinger","year":"1998","journal-title":"Epilepsia"},{"issue":"3","key":"10.1002\/14651858.CD005399.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0920-1211(90)90079-B","article-title":"Epilepsy in a population of mentally retarded children and adults","volume":"6","author":"Forsgren","year":"1990","journal-title":"Epilepsy Research"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD005399.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.2466\/pr0.1995.77.3f.1208","article-title":"Behavioural effects of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"77","author":"Gay","year":"1995","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD005399.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-3148.1989.tb00022.x","article-title":"The social and behavioural functioning of people with mental handicaps attending adult training centres: a comparison with those with and without epilepsy","volume":"2","author":"Gillies","year":"1989","journal-title":"Mental Handicap Research"},{"key":"10.1002\/14651858.CD005399.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1528-1157.1991.tb04711.x","article-title":"Epilepsy in children with mental retardation: a cohort study","volume":"34","author":"Goulden","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB48|cit48","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2005"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-8749.1984.tb04399.x","article-title":"The development of psychiatric disorder among school children with epilepsy","volume":"26","author":"Hoare","year":"1984","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1002\/14651858.CD005399.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Commission on Classification and Terminology of the ILAE: proposal for revised clinical and EEG classification of epileptic seizures","volume":"22","year":"1981","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Commission on Classification and Terminology of the ILAE: proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","year":"1989","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3476(96)70336-0","article-title":"Efficacy of gabapentin therapy in children with refractory partial seizures","volume":"128","author":"Khurana","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD005399.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1528-1157.1996.tb00517.x","article-title":"Behavioral side effects of gabapentin in children","volume":"37","author":"Lee","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005399.pub2-BIB54|cit54","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005399.pub2-BIB55|cit55","volume-title":"Services for People with Learning Disabilities and Challenging Behaviour or Mental Health Needs","author":"Mansell","year":"1993"},{"key":"10.1002\/14651858.CD005399.pub2-BIB56|cit56","first-page":"27","article-title":"Epilepsy in institutionalized patients with encephalopathy: clinical aspects and nosological considerations","volume":"98","author":"Mariani","year":"1993","journal-title":"American Journal of Mental Retardation"},{"key":"10.1002\/14651858.CD005399.pub2-BIB57|cit57","first-page":"57","article-title":"Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability","volume":"1","author":"Mikati","year":"1998","journal-title":"Journal of Intellectual Disability Research"},{"issue":"5","key":"10.1002\/14651858.CD005399.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1352\/0895-8017(2003)108<293:POEAAH>2.0.CO;2","article-title":"Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability","volume":"108","author":"Morgan","year":"2003","journal-title":"American Journal of Mental Retardation"},{"key":"10.1002\/14651858.CD005399.pub2-BIB59|cit59","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD005399.pub2-BIB60|cit60","volume-title":"Evidence-Based Medicine: How to Practice and Teach EBM","author":"Sackett","year":"1997"},{"key":"10.1002\/14651858.CD005399.pub2-BIB61|cit61","first-page":"511","article-title":"Epilepsy in school children with intellectual impairments in Sheffield: the size and nature of the problem and its implications in service provision","volume":"33","author":"Shepherd","year":"1989","journal-title":"Journal of Mental Dificiency Research"},{"key":"10.1002\/14651858.CD005399.pub2-BIB62|cit62","first-page":"12","article-title":"Epilepsy in Down's syndrome: clinical aspects and possible mechanisms","volume":"98","author":"Stafstrom","year":"1993","journal-title":"American Journal of Mental Retardation"},{"issue":"6","key":"10.1002\/14651858.CD005399.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002018-199615060-00003","article-title":"A comparative review of the adverse effects of anticonvulsants in children with epilepsy","volume":"15","author":"Wallace","year":"1996","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD005399.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jmg.28.6.395","article-title":"On the incidence of fits and mental retardation in tuberous sclerosis","volume":"6","author":"Webb","year":"1991","journal-title":"Journal of Medical Genetics"},{"issue":"12","key":"10.1002\/14651858.CD005399.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1528-1157.1995.tb01063.x","article-title":"Gabapentin toxicity in children manifesting as behavioural changes","volume":"36","author":"Wolf","year":"1995","journal-title":"Epilepsia"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005399.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T00:00:00Z","timestamp":1441238400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005399.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:48:56Z","timestamp":1628531336000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005399.pub2"}},"subtitle":[],"editor":[{"given":"Michael","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":65,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005399.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,7,18]]}}}